Elevate Uranium Ltd

As of June 30, 2024, Elevate Uranium Ltd carries a market capitalization of 74.80M, placing it among publicly traded companies globally. Its enterprise value stands at 68.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Elevate Uranium Ltd's next confirmed earnings release is scheduled for March 11, 2027.

As of June 30, 2024, Elevate Uranium Ltd has 308.45M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, Elevate Uranium Ltd maintains a current ratio of 7.58, meaning it holds 7.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2024, Elevate Uranium Ltd posted a negative return on equity (ROE) of -92.30, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -83.35, reflecting losses generated across the asset base.

As of the close on October 22, 2026, Elevate Uranium Ltd's stock has declined approximately 42.00% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.17.

These figures cover the twelve months ended June 30, 2024. EBITDA reached -6.91M, while operating income came in at -6.53M.

As of June 30, 2024, Elevate Uranium Ltd holds 6.75M in cash and equivalents against 46,205.48 in total debt, resulting in a net debt position of -6.75M. Total book value stands at 7.33M, with working capital of 5.90M providing operational flexibility.

These figures cover the twelve months ended June 30, 2024.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -8.40, meaning Elevate Uranium Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Elevate Uranium Ltd's most recent stock split took place on November 5, 2014 with a 100:1 split ratio.